195 related articles for article (PubMed ID: 9558362)
1. The impact of all-trans-retinoic acid on the coagulopathy of acute promyelocytic leukemia.
Barbui T; Finazzi G; Falanga A
Blood; 1998 May; 91(9):3093-102. PubMed ID: 9558362
[No Abstract] [Full Text] [Related]
2. Coagulopathy of acute promyelocytic leukemia.
Falanga A; Barbui T
Acta Haematol; 2001; 106(1-2):43-51. PubMed ID: 11549776
[TBL] [Abstract][Full Text] [Related]
3. A case of ischemic stroke in acute promyelocytic leukemia at initial presentation. Relevance of all-trans retinoic acid treatment.
Carella AM; Antonucci G; Conte M; Di Pumpo M; Antonucci E; Ponziano E
Cardiovasc Hematol Disord Drug Targets; 2010 Mar; 10(1):1-6. PubMed ID: 20041837
[TBL] [Abstract][Full Text] [Related]
4. Acute promyelocytic leukaemia in the all trans retinoic acid era.
DeLoughery TG; Goodnight SH
Med Oncol; 1996 Dec; 13(4):233-40. PubMed ID: 9152974
[TBL] [Abstract][Full Text] [Related]
5. Thrombotic complications in acute promyelocytic leukemia during all-trans-retinoic acid therapy.
Pogliani EM; Rossini F; Casaroli I; Maffe P; Corneo G
Acta Haematol; 1997; 97(4):228-30. PubMed ID: 9158667
[TBL] [Abstract][Full Text] [Related]
6. All-trans retinoic acid for the treatment of acute promyelocytic leukemia in pregnancy.
Incerpi MH; Miller DA; Posen R; Byrne JD
Obstet Gynecol; 1997 May; 89(5 Pt 2):826-8. PubMed ID: 9166337
[TBL] [Abstract][Full Text] [Related]
7. The impact of oral arsenic and all-trans-retinoic acid on coagulopathy in acute promyelocytic leukemia.
Zhu HH; Guo ZP; Jia JS; Jiang Q; Jiang H; Huang XJ
Leuk Res; 2018 Feb; 65():14-19. PubMed ID: 29232592
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of recombinant human soluble thrombomodulin in induction therapy for acute promyelocytic leukemia.
Matsuda K; Jo T; Toyama K; Nakazaki K; Matsui H; Fushimi K; Yasunaga H
Thromb Res; 2021 Jun; 202():173-175. PubMed ID: 33866226
[No Abstract] [Full Text] [Related]
9. [Coagulopathy and differentiation syndrome: the main complications of the initial treatment of acute promyelocytic leukemia].
Korístek Z; Zák P
Vnitr Lek; 2008; 54(7-8):745-50. PubMed ID: 18780573
[TBL] [Abstract][Full Text] [Related]
10. Low molecular weight heparin in the prophylaxis and treatment of disseminated intravascular coagulation in acute promyelocytic leukemia.
Gillis S; Dann EJ; Eldor A
Eur J Haematol; 1995 Jan; 54(1):59-60. PubMed ID: 7859878
[No Abstract] [Full Text] [Related]
11. Acute promyelocytic leukemia in pregnancy: all-trans retinoic acid as a newer therapeutic option.
Celo JS; Kim HC; Houlihan C; Canavan BF; Manzullo GP; Saidi P
Obstet Gynecol; 1994 May; 83(5 Pt 2):808-11. PubMed ID: 8159357
[TBL] [Abstract][Full Text] [Related]
12. [Disseminated intravascular coagulation in malignant neoplasms].
Kato A
Rinsho Ketsueki; 2010 Jan; 51(1):37-43. PubMed ID: 20134138
[No Abstract] [Full Text] [Related]
13. [Thrombosis and DIC in hematological malignancies].
Asakura H
Rinsho Ketsueki; 2014 Oct; 55(10):2066-75. PubMed ID: 25297773
[No Abstract] [Full Text] [Related]
14. All-trans-retinoic acid in acute promyelocytic leukemia and its potential in other hematologic malignancies.
Tallman MS
Semin Hematol; 1994 Oct; 31(4 Suppl 5):38-48. PubMed ID: 7831584
[TBL] [Abstract][Full Text] [Related]
15. Pathogenesis and management of the bleeding diathesis in acute promyelocytic leukaemia.
Falanga A; Rickles FR
Best Pract Res Clin Haematol; 2003 Sep; 16(3):463-82. PubMed ID: 12935963
[TBL] [Abstract][Full Text] [Related]
16. All trans retinoic acid treatment for patients with acute promyelocytic leukemia.
Fenaux P; Castaigne S; Chomienne C; Dombret H; Degos L
Leukemia; 1992; 6 Suppl 1():64-6. PubMed ID: 1548938
[No Abstract] [Full Text] [Related]
17. Advances in the management of coagulopathy in acute promyelocytic leukemia.
Sanz MA; Montesinos P
Thromb Res; 2020 Jul; 191 Suppl 1():S63-S67. PubMed ID: 32736781
[TBL] [Abstract][Full Text] [Related]
18. Rapid improvement of coagulopathy by all-trans retinoic acid in acute promyelocytic leukemia.
Kawai Y; Watanabe K; Kizaki M; Murata M; Kamata T; Uchida H; Moriki T; Yokoyama K; Tokuhira M; Nakajima H
Am J Hematol; 1994 Jul; 46(3):184-8. PubMed ID: 8192147
[TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up of hemostatic molecular markers during remission induction therapy with all-trans retinoic acid for acute promyelocytic leukemia. Keio Hematology-Oncology Cooperative Study Group (KHOCS).
Watanabe R; Murata M; Takayama N; Tokuhira M; Kizaki M; Okamoto S; Kawai Y; Watanabe K; Murakami H; Kikuchi M; Nakamura S; Ikeda Y
Thromb Haemost; 1997 Apr; 77(4):641-5. PubMed ID: 9134635
[TBL] [Abstract][Full Text] [Related]
20. Coagulation disorders associated with acute promyelocytic leukemia: corrective effect of all-trans retinoic acid treatment.
Dombret H; Scrobohaci ML; Ghorra P; Zini JM; Daniel MT; Castaigne S; Degos L
Leukemia; 1993 Jan; 7(1):2-9. PubMed ID: 8418375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]